Core Viewpoint - The financial performance of Qicai Chemical (300758) has shown significant declines in both revenue and net profit for the third quarter of 2025, indicating potential challenges ahead for the company [5][6][11]. Financial Performance Summary - The total revenue for the first three quarters of 2025 was approximately 1.12 billion yuan, a decrease of 3.04% year-on-year [6][12]. - The net profit attributable to shareholders for the same period was approximately 73.39 million yuan, down 38.96% year-on-year [6][12]. - In Q3 2025 alone, the net profit dropped to approximately 20.91 million yuan, reflecting a 60.56% decline compared to the same quarter last year [5][6]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was approximately 32.06 million yuan, a significant decrease of 72.39% year-on-year [6][12]. - Total assets at the end of the reporting period were approximately 3.89 billion yuan, an increase of 4.63% from the previous year [7][12]. Shareholder Information - The top ten shareholders include Anshan Huifeng Investment Group Co., Ltd., holding 19.37% of shares, and Xu Huixiang, holding 11.89% [9][10]. - The company has a total of 28,407 ordinary shareholders as of the end of the reporting period [11]. Trading Information - On October 22, 2025, Qicai Chemical's stock closed at 13.63 yuan, down 0.87%, with a turnover rate of 1.3% and a trading volume of 47,800 shares [1][2]. - There was a net outflow of 831.35 million yuan from institutional investors on the same day, while retail investors saw a net inflow of 471.76 million yuan [2][5]. Major Transactions - A significant block trade occurred on October 22, 2025, at a discount of 19.3%, totaling approximately 599.94 million yuan [3][5].

Group 1 - The core transaction involved 545,400 shares of Qicai Chemical, with a total transaction value of 5.9994 million yuan, representing 8.45% of the total trading volume on that day [1][2] - The transaction price was set at 11 yuan per share, which reflects a discount of 19.3% compared to the market closing price of 13.63 yuan [1][2]

Core Insights - Q3 2025 revenue reached 360 million yuan, a year-on-year decrease of 13.32% [2] - Net profit attributable to shareholders was 20.91 million yuan, down 60.56% year-on-year [2] - For the first three quarters, total revenue was 1.119 billion yuan, a decline of 3.04% year-on-year [2] - Net profit attributable to shareholders for the first three quarters was 73.39 million yuan, a decrease of 38.96% year-on-year [2]

Core Viewpoint - Q3 2025 financial results of Qicai Chemical (300758.SZ) show a significant decline in both revenue and net profit compared to the previous year [1] Financial Performance - The company's operating revenue for Q3 2025 was 360 million yuan, representing a year-on-year decrease of 13.32% [1] - The net profit attributable to shareholders of the listed company was 20.9143 million yuan, down 60.56% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 20.195 million yuan, reflecting a year-on-year decline of 58.15% [1]

Core Viewpoint - Qichai Chemical (300758.SZ) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters was 1.119 billion yuan, a year-on-year decrease of 3.04% [1] - The net profit attributable to shareholders of the listed company was 73.3886 million yuan, down 38.96% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 79.8067 million yuan, a decrease of 27.43% year-on-year [1] - Basic earnings per share were 0.18 yuan [1]

证券代码：300758 证券简称：七彩化学 公告编号：2025-081 鞍山七彩化学股份有限公司 关于 2025 年前三季度计提资产减值准备的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 鞍山七彩化学股份有限公司（以下简称"公司"）根据《企业会计准则》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关规定的要求，为了更加真实、准确的 反映公司 2025 年 9 月 30 日的财务状况和 2025 年第三季度的经营成果，基于谨 慎性原则，对合并范围内各公司存在减值迹象的资产进行了减值测试，并根据减 值测试的结果相应计提了减值准备，本次事项已经公司第七届董事会审计委员会 2025 年第四次会议审议通过，具体如下： 一、计提减值准备的资产范围和金额 单位：元 | 名称 | 2025 （损失以负号填列） | 年前三季度计提减值准备金额填列 | | --- | --- | --- | | 1、信用减值损失 | | 270,748.24 | | 其中：应收账款坏账损失 | | 96,148.59 ...

第七届董事会第十一次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 鞍山七彩化学股份有限公司（以下简称"公司"）于 2025 年 10 月 21 日在 辽宁省鞍山市海城市腾鳌镇经济开发区一号路八号，公司三楼会议室以现场结合 通讯方式召开了第七届董事会第十一次会议。会议通知已于 2025 年 10 月 11 日 以邮件、专人送达方式通知公司全体董事。本次会议应出席董事 8 名，实际出席 会议董事 8 名。本次会议由董事长徐惠祥先生主持，高级管理人员列席了会议。 本次会议的召开和表决程序符合《中华人民共和国公司法》（以下简称《公司法》） 等法律法规以及《公司章程》的有关规定，会议合法有效。 二、董事会会议审议情况 本次会议以记名方式投票表决，审议通过以下事项： 审议通过《关于 2025 年第三季度报告的议案》 公司《2025 年第三季度报告》的编制符合法律法规及深圳证券交易所的相 关规定，报告内容真实、准确、完整地反映了公司的实际情况，不存在任何虚假 记载、误导性陈述或者重大遗漏。 证券代码：300758 证券简称：七彩化学 ...

Core Viewpoint - Qicai Chemical reported a decline in both revenue and net profit for the third quarter of 2025, indicating potential challenges in its financial performance [1] Financial Performance - In Q3 2025, the company achieved an operating income of 360 million yuan, a year-on-year decrease of 13.32% [1] - The net profit attributable to shareholders was 20.91 million yuan, down 60.56% year-on-year [1] - For the first three quarters of 2025, the company reported an operating income of 1.119 billion yuan, a decline of 3.04% compared to the previous year [1] - The net profit attributable to shareholders for the first three quarters was 73.39 million yuan, reflecting a decrease of 38.96% year-on-year [1]

Financial Performance - The company's revenue for Q3 2025 was ¥360,112,423.95, a decrease of 13.32% compared to the same period last year[5]. - Net profit attributable to shareholders was ¥20,914,328.16, down 60.56% year-on-year[5]. - The basic earnings per share decreased by 61.54% to ¥0.05[5]. - Total operating revenue for the current period is ¥1,119,170,486, a decrease of 3.0% from ¥1,154,203,999 in the previous period[19]. - Operating profit decreased to ¥86,633,489.31, down 38.8% from ¥141,565,900.56 in the previous period[20]. - Net profit for the current period is ¥77,186,734.15, a decline of 38.7% compared to ¥125,900,838.16 in the previous period[20]. - Basic and diluted earnings per share decreased to ¥0.18 from ¥0.30 in the previous period[21]. Assets and Liabilities - Total assets increased by 4.63% to ¥3,894,965,106.68 compared to the end of the previous year[5]. - The total assets of the company as of September 30, 2025, amounted to CNY 3,894,965,106.68, an increase from CNY 3,722,735,799.91 at the beginning of the period[15]. - Current assets totaled CNY 1,284,255,522.94, compared to CNY 1,265,635,585.22 at the start of the period, reflecting a growth of approximately 1.5%[15]. - The company's total liabilities reached CNY 1,935,347,350.24, up from CNY 1,839,748,659.80, indicating an increase of approximately 5.2%[17]. - The equity attributable to the parent company was CNY 1,791,093,045.71, compared to CNY 1,713,599,210.47 at the beginning of the period, showing an increase of about 4.5%[17]. - The total liabilities to equity ratio stands at approximately 0.99, indicating a balanced leverage position[17]. Cash Flow - Cash flow from operating activities for the year-to-date period decreased by 72.39% to ¥32,059,063.11[5]. - Cash flow from operating activities generated a net amount of ¥32,059,063.11, down 72.5% from ¥116,115,414.35 in the previous period[21]. - Cash flow from investing activities resulted in a net outflow of ¥154,409,387.29, compared to a net outflow of ¥89,238,409.81 in the previous period[22]. - Cash flow from financing activities generated a net inflow of ¥109,311,804.18, compared to a net outflow of ¥60,953,435.77 in the previous period[22]. - The ending cash and cash equivalents balance is ¥262,836,963.27, an increase from ¥211,696,021.70 in the previous period[22]. Investments and Expenses - The company reported a significant decline in investment income, down 63.50% to ¥3,948,427.40 due to losses from joint ventures[9]. - The company experienced a 69.21% increase in trading financial assets, primarily due to the purchase of US dollar cash funds[8]. - The company recorded a 203.81% increase in non-operating expenses, primarily due to increased losses from the disposal of non-current assets[9]. - The company's long-term investments increased to CNY 516,682,070.65 from CNY 503,850,041.82, marking a growth of approximately 2.6%[16]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 28,407[11]. - The company reported a total of 770,482 restricted shares at the beginning of the period, with 753,270 shares released during the period[14]. Inventory and Receivables - Inventory increased to CNY 420,927,248.22 from CNY 384,822,046.17, representing a rise of about 9.4%[16]. - Accounts receivable decreased to CNY 242,391,742.97 from CNY 263,271,775.15, reflecting a decline of about 7.9%[15]. Audit Status - The financial report for the third quarter has not been audited[23].

Group 1 - The core point of the article is that Qicai Chemical reported a significant decline in both revenue and net profit for the third quarter and the first three quarters of the year [1] Group 2 - In the third quarter, the company's revenue was 360 million yuan, a decrease of 13.32% [1] - The net profit for the third quarter was 20.91 million yuan, down 60.56% [1] - For the first three quarters, the total revenue was 1.119 billion yuan, reflecting a decline of 3.04% [1] - The net profit for the first three quarters was 73.39 million yuan, which represents a decrease of 38.96% [1]